Elpiscience, a Shanghai-based biopharmaceutical company has completed a $100 million Series B round of funding led by specialist healthcare GP Hyfinity Investments.
Tencent Holdings, GTJA Investment Group, Dyee Capital, Oriza Holdings, Ming Bioventures, WisdoMont Asset Management, and Parkway Global also joined the round. Existing investors Lilly Asia Ventures (LAV),...
Beijing-based autonomous driving solutions provider PhiGent Robotics has raised a USD30m Series A round led by Ince Capital. Previous investors such as Atypical Ventures, 5Y Capital, and GSR Ventures re-upped.
China-based BlueRun Ventures has closed its third US dollar-denominated China fund and third renminbi vehicle with aggregate commitments of CNY 5.5bn (USD 819m).
Temasek Holdings-owned Azalea Investment Management is further expanding retail exposure to private equity through its latest issue of bonds – worth USD 754m in total – backed by LP interests in funds.
Hong Kong’s Betatron Venture Group has reached a first close of USD 15m on its latest fund, which will make early-stage investments across South and Southeast Asia. The target is USD 50m.